Literature DB >> 1892321

The carbohydrate diversity of human respiratory mucins: a protection of the underlying mucosa?

G Lamblin1, M Lhermitte, A Klein, N Houdret, A Scharfman, R Ramphal, P Roussel.   

Abstract

Human respiratory mucins consist of a family of glycoproteins with different peptides in which glycosylation, the major post-translational phenomenon, is responsible for about 70 to 80% of the weight of these molecules. This glycosylation generates a remarkable diversity of O-glycosidically linked carbohydrate chains, which are expressed as several hundreds of different chains in a single person. These chains, which can vary from one to about 20 sugars, may be neutral, sialylated, or sulfated. They bear multiple epitopes. Some antigenic determinants such as ABO, Leb antigens in secretor individuals, Lea, or X or Y antigens have been identified. There is increasing evidence that, among other functions, this diversity of chains allows many interactions with microorganisms and may be an important factor in maintaining the sterility of the respiratory tree. In certain pathologic situations such as cystic fibrosis, which is associated with colonization by Pseudomonas aeruginosa, the hypothesis of an alteration of this interaction is open.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1892321     DOI: 10.1164/ajrccm/144.3_pt_2.S19

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  19 in total

1.  Alternative splicing of repetitive units is responsible for the polydispersities of integumentary mucin B.1 (FIM-B.1) from Xenopus laevis.

Authors:  W Joba; W Hoffmann
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

Review 2.  Physicochemical properties of mucus and their impact on transmucosal drug delivery.

Authors:  Jasmim Leal; Hugh D C Smyth; Debadyuti Ghosh
Journal:  Int J Pharm       Date:  2017-09-14       Impact factor: 5.875

3.  Mucins secreted by a transformed cell line derived from human tracheal gland cells.

Authors:  J M Lo-Guidice; M D Merten; G Lamblin; N Porchet; M C Houvenaghel; C Figarella; P Roussel; J M Perini
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

4.  Binding of Haemophilus influenzae to purified mucins from the human respiratory tract.

Authors:  J Davies; I Carlstedt; A K Nilsson; A Håkansson; H Sabharwal; L van Alphen; M van Ham; C Svanborg
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

Review 5.  Human airway mucin glycosylation: a combinatory of carbohydrate determinants which vary in cystic fibrosis.

Authors:  G Lamblin; S Degroote; J M Perini; P Delmotte; A Scharfman; M Davril; J M Lo-Guidice; N Houdret; V Dumur; A Klein; P Rousse
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

Review 6.  Chronic rhinosinusitis pathogenesis.

Authors:  Whitney W Stevens; Robert J Lee; Robert P Schleimer; Noam A Cohen
Journal:  J Allergy Clin Immunol       Date:  2015-12       Impact factor: 10.793

7.  Pseudomonas aeruginosa outer membrane adhesins for human respiratory mucus glycoproteins.

Authors:  C Carnoy; A Scharfman; E Van Brussel; G Lamblin; R Ramphal; P Roussel
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

Review 8.  O-linked protein glycosylation structure and function.

Authors:  E F Hounsell; M J Davies; D V Renouf
Journal:  Glycoconj J       Date:  1996-02       Impact factor: 2.916

9.  Permanent exposure of mucin-secreting HT-29 cells to benzyl-N-acetyl-alpha-D-galactosaminide induces abnormal O-glycosylation of mucins and inhibits constitutive and stimulated MUC5AC secretion.

Authors:  S Hennebicq-Reig; T Lesuffleur; C Capon; C De Bolos; I Kim; O Moreau; C Richet; B Hémon; M A Recchi; E Maës; J P Aubert; F X Real; A Zweibaum; P Delannoy; P Degand; G Huet
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

10.  Exploring the attachment of the Mediterranean medicinal leech (Hirudo verbana) to porous substrates.

Authors:  Tim Kampowski; Lara-Louise Thiemann; Lukas Kürner; Thomas Speck; Simon Poppinga
Journal:  J R Soc Interface       Date:  2020-07-15       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.